Cargando…
Dexamethasone intravitreal implant for the treatment of noninfectious uveitis
Uveitis can be a sight-threatening eye disease with significant morbidity. Corticosteroids remain the mainstay of treatment of uveitis and provide an effective treatment against ocular inflammation. However, the various modes available for corticosteroid drug delivery can carry significant ocular an...
Autores principales: | Hunter, Rebecca S, Lobo, Ann-Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3225458/ https://www.ncbi.nlm.nih.gov/pubmed/22140307 http://dx.doi.org/10.2147/OPTH.S17419 |
Ejemplares similares
-
Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant
por: Myung, Jane S, et al.
Publicado: (2010) -
Intravitreal Dexamethasone Implants for Refractory Macular Edema in Eyes with Noninfectious Uveitis
por: Kang, Eugene Yu-Chuan, et al.
Publicado: (2021) -
Management of noninfectious posterior uveitis with intravitreal drug therapy
por: Tan, Hui Yi, et al.
Publicado: (2016) -
Post-marketing surveillance study of the safety of dexamethasone intravitreal implant in patients with retinal vein occlusion or noninfectious posterior segment uveitis
por: Tufail, Adnan, et al.
Publicado: (2018) -
Intravitreal Dexamethasone Implant in the Treatment of Non-infectious Uveitis
por: Hasanreisoğlu, Murat, et al.
Publicado: (2019)